NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000050732

Registered date:31/03/2023

A web-based survey on itching in patients with seasonal allergic conjunctivitis in 2023

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedseasonal allergic conjunctivitis
Date of first enrollment2023/03/31
Target sample size1000
Countries of recruitmentJapan
Study typeOthers,meta-analysis etc
Intervention(s)

Outcome(s)

Primary OutcomeThe situation of eye itch The relationship between eye itch and eye drop behavior
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaMedical professionals (doctors, pharmacists, nurses, etc.) Subjects engaged in pharmaceuticals and medical devices industry Subjects engaged in pharmaceuticals distributor Subjects engaged in information provision services, research services, and advertising Subjects with severe allergic conjunctival disease (vernal keratoconjunctivitis , atopic keratoconjunctivitis)

Related Information

Contact

public contact
Name Hirotsugu Kishimoto
Address 4-20, Ofukacho, Kita-ku, Osaka Japan 5308552
Telephone 06-4802-9337
E-mail clinical@santen.co.jp
Affiliation Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group
scientific contact
Name Reiko Miyahara
Address 4-20, Ofukacho, Kita-ku, Osaka Japan
Telephone 06-4802-9337
E-mail clinical@santen.co.jp
Affiliation Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group